PRINSTON INC FDA Approval ANDA 203468

ANDA 203468

PRINSTON INC

FDA Drug Application

Application #203468

Application Sponsors

ANDA 203468PRINSTON INC

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET, EXTENDED RELEASE;ORAL500MG0LEVETIRACETAMLEVETIRACETAM
002TABLET, EXTENDED RELEASE;ORAL750MG0LEVETIRACETAMLEVETIRACETAM

FDA Submissions

UNKNOWN; ORIG1AP2015-05-21
LABELING; LabelingSUPPL3AP2021-11-16STANDARD
LABELING; LabelingSUPPL5AP2021-11-16STANDARD
LABELING; LabelingSUPPL6AP2021-11-16STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL7AP2021-11-17UNKNOWN
LABELING; LabelingSUPPL8AP2021-11-16STANDARD

Submissions Property Types

ORIG1Null42
SUPPL3Null15
SUPPL5Null15
SUPPL6Null15
SUPPL7Null7
SUPPL8Null7

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

PRINSTON INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 203468
            [companyName] => PRINSTON INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"LEVETIRACETAM","activeIngredients":"LEVETIRACETAM","strength":"500MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"LEVETIRACETAM","activeIngredients":"LEVETIRACETAM","strength":"750MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"05\/21\/2015","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2015-05-21
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.